The burden of COPD in the U.K.: Results from the Confronting COPD survey

Respiratory Medicine

Volumn 97, Issue SUPPL. C, 2003, Pages

  Britton, Mark ^a  

^a ST PETER S HOSPITAL   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease (COPD); Direct costs; Healthcare resource use; Indirect costs; Lost productivity; U.K.

Indexed keywords

AMFEBUTAMONE; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; OXYGEN; THEOPHYLLINE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST OF ILLNESS; DEVELOPED COUNTRY; DISEASE COURSE; DISEASE EXACERBATION; DRUG COST; EARLY DIAGNOSIS; ECONOMIC EVALUATION; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HEALTH SERVICE; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INTERVIEW; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORBIDITY; MORTALITY; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SOCIETY; UNITED KINGDOM;

ABSENTEEISM; AGED; AGED, 80 AND OVER; COST OF ILLNESS; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HEALTH RESOURCES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; RESPIRATORY SYSTEM AGENTS;

EID: 0037370334     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(03)80027-6     Document Type: Article

References (26)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Executive Summary. NHLBI/WHO Workshop Report 2001.
2. Calverley P, Bellamy D. The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction? Thorax 2000; 55: 78-82.
3. Calverley PMA, Sondhi S. The burden of obstructive lung disease in the U.K. - COPD and asthma. Poster presented at the British Thoracic Society meeting. December 1998.
4. Siafakas NM, Vermeire P, Pride NB, et al. ERS-consensus statement. Optimal assessment and management of chronic obstructive pulmonary disease. Eur Respir Rev 1995; 8: 1398-1420.
5. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
6. British Thoracic Society. The burden of lung disease. A statistics report from the British Thoracic Society. November 2001. http://www.brit-thoracic.org.uk/pdf/BTSpages.pdf
7. Office for National Statistics (2000). Mortality statistics by cause. Series DH2 No. 26. The Stationery Office: London.
8. General Register Office (2000). Annual Report 1999. Edinburgh: General Register Office.
9. General Register Office (2000). Annual Report 1999. Northern Ireland: Statistics and Research Agency:
10. Ferrer M, Aloso J, Morera J, et al. Chronic obstructive pulmonary disease state and health-related quality of life. Ann Intern Med 1997; 127: 1072-1079.
11. Seemungal TAR, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
12. Spencer S, Jones P. Annual rate of health status decline in COPD patients is significantly related to the frequency of acute exacerbations. Eur Respir J 1999; 14(Suppl 30): 19S.
13. Spencer S, Jones PW. Patients with recurrent exacerbations of chronic bronchitis (AECB) have poorer health and recover more slowly and less completely following an acute episode. Am J Respir Crit Care Med 2001; 163: A769.
14. Royal College of General Practitioners, Office of Population Censuses and Surveys, Department of Health. Morbidity statistics from general practice. Third National Study 1991-1992. London:HMSO, 1995.
15. Department of Health (2001). Hospital Episode Statistics 1999/2000. http://doh.gov.uk/hes/index.html.
16. Damiani M, Dixon J. Managing the pressure: emergency hospital admissions in London, 1997-2001. London: King's Fund, 2002.
17. National Respiratory Training Centre. Impact of Respiratory Conditions: a guide for Primary Care Organisations. Warwick: NRTC, 2002.
18. Department of Health. Saving lives: our healthier nation. London: Department of Health, 1999.
19. Barnes PJ. Managing chronic obstructive pulmonary disease. London: Science Press, 1999.
20. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in men and women in the U.K. Thorax 2000; 55: 789-794.
21. British Thoracic Society/MORI. The Burden of Lung Disease Survey 2002. http://www.brit-thoracic.org.uk
22. Rennard S, Decramer M. Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20: 799-805.
23. Decramer M, Pride NB, Soriano JB, et al. International differences of the burden of COPD. Chest 2003 (in press)
24. Halpern MT, Musin A, Sondhi S. Economic analysis of the Confronting COPD Survey: methodology. Respir Med 2003; 97(Suppl C): S15-S22.
25. Price MJ, Hurrell C, Efthimiou J, Medley HV. Health care costs of treating exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1999; 14: 30s.
26. Office for National Statistics population estimates. http://www.statistics.gov.uk